yingweiwo

TLR

TLR

A group of proteins known as toll-like receptors (TLRs) are essential components of the innate immune system. They are single, membrane-spanning, non-catalytic receptors that recognize structurally conserved molecules derived from microbes and are typically expressed in sentinel cells like macrophages and dendritic cells. Once these microbes have gotten past physical barriers like the skin or mucosa of the gastrointestinal tract, TLRs recognize them and trigger immune cell responses.

TLR1 through TLR13 are among the TLRs, along with TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, TLR12, and TLR13. Toll-Like Receptors (TLRs) are involved in both the detection of endogenous danger signals and the early innate immune response to encroaching pathogens. TLRs are homologs of the Drosophila Toll protein, which was found to be crucial for defense against microbial infection. They are evolutionarily conserved receptors. TLRs identify pathogen-associated microbial patterns (PAMPs), which are only expressed by microbial pathogens and are highly conserved structural motifs.

TLR related products

Structure Cat No. Product Name CAS No. Product Description
Biotin-labeled ODN 1668 sodium V78441 Biotin-labeled ODN 1668 sodium Biotin-labeled ODN 1668 (sodium) is a class B CpG ODN and a TLR9 agonist.
Biotin-labeled ODN 1826 sodium V78442 Biotin-labeled ODN 1826 sodium Biotin-labeled ODN 1826 (sodium) is a class B CpG ODN and a TLR9 agonist.
Biotin-labeled ODN 2088 sodium V78443 Biotin-labeled ODN 2088 sodium Biotin-labeled ODN 2088 (sodium) is a TLR3, TLR7 and TLR9 inhibitor.
Biotin-labeled ODN 2216 sodium V78444 Biotin-labeled ODN 2216 sodium Biotin-labeled ODN 2216 (sodium) is a TLR9 agonist.
Biotin-labeled ODN 2395 sodium V78445 Biotin-labeled ODN 2395 sodium Biotin-labeled ODN 2395 (sodium) is a class C CpG ODN and a TLR9 agonist.
Biotin-labeled ODN TTAGGG sodium V78446 Biotin-labeled ODN TTAGGG sodium Biotin-labeled ODN TTAGGG (sodium) is an inhibitor oligonucleotide that is an antagonist of TLR9, AIM2 and cGAS.
BNT411 V87025 BNT411 2296821-50-4 BNT411 is a selective TLR7 agonist that can induce IFNa release in vitro and in vivo.
Cavrotolimod (AST-008) V74356 Cavrotolimod (AST-008) 2378664-12-9 Cavrotolimod is a spherical nucleic acid (SNA) modified with B-type CpG oligonucleotides that stimulates TLR9 and elicits an immune response.
Cavrotolimod sodium (AST-008 sodium) V78661 Cavrotolimod sodium (AST-008 sodium) Cavrotolimodsodium is a spherical nucleic acid (SNA) modified with B-type CpG oligonucleotides that stimulates TLR9 and elicits an immune response.
CAY10614 V74376 CAY10614 1202208-36-3 CAY10614 is a potent TLR4 antagonist.
Chitohexaose hexahydrochloride V74360 Chitohexaose hexahydrochloride 127171-88-4 Chitohexaose hexa HCl is a chitosan oligosaccharide with anti-inflammatory activities.
Chloranil V86903 Chloranil 118-75-2 Chloranil activates the TLR4 signaling pathway by enhancing the expression of TLR4 and MyD88, leading to neuroinflammation and cell damage.
CL-097 V51783 CL-097 1026249-18-2 CL097 is a potent TLR7 and TLR8 agonist that induces pro-inflammatory cytokines in macrophages.
CL-104773 V51012 CL-104773 802980-92-3 TLR2 antagonists; JAK2 inhibitor
Cobitolimod V74355 Cobitolimod 1226822-98-5 Cobitolimod is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity.
Cobitolimod sodium V74354 Cobitolimod sodium 1527479-55-5 Cobitolimod sodium is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity.
CpG ODN 10101 sodium V87020 CpG ODN 10101 sodium CpG ODN 10101 sodium is a synthetic oligodeoxynucleotide (ODN) that is a Toll-like receptor 9 (TLR9) agonist.
CU-115 V51027 CU-115 2471982-20-2 CU-115 is a disabling TLR8 antagonist (IC50=1.04 µM) and shows activity against TLR8 and TLR7 (IC50=>50 µM).
CU-CPT-8m V3815 CU-CPT-8m 125079-83-6 CU-CPT-8m is a novel, potent and specific antagonist ofToll-like receptor 8 (TLR8)with immunomodulatory effects.
CU-CPT-9a V3816 CU-CPT-9a 2165340-32-7 CU-CPT-9a, an analog ofCU-CPT-8m, is a potent and specificantagonist/inhibitor of TLR8 (Toll-like receptor 8) (IC50 = 0.5 nM) with the potential to be used for treating autoimmune diseases.
Contact Us